Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
Nature Communications|April 2, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasmsDiana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2021
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory MyelofibrosisJohn Mascarenhas, Rami S Komrokji, Francesca Palandri, et al.
Leukemia|March 9, 2018
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetTiziano Barbui, Ayalew Tefferi, Alessandro M Vannucchi, et al.
Leukemia & Lymphoma|January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
American Journal of Hematology|March 31, 2012
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH SymposiumOmar Abdel-Wahab, Animesh Pardanani, Olivier A Bernard, et al.
Communications Biology|May 4, 2021
Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleationMaria Feola, Andrea Zamperone, Daniel Moskop, et al.
Blood|May 6, 2006
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)Ayalew Tefferi, Giovanni Barosi, Ruben A Mesa, et al.
Nature|July 5, 2019
Somatic mutations and cell identity linked by Genotyping of TranscriptomesAnna S Nam, Kyu-Tae Kim, Ronan Chaligne, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
Nature Communications|April 2, 2022
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasmsDiana Saleiro, Jeremy Q Wen, Ewa M Kosciuczuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2021
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory MyelofibrosisJohn Mascarenhas, Rami S Komrokji, Francesca Palandri, et al.
Leukemia|March 9, 2018
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetTiziano Barbui, Ayalew Tefferi, Alessandro M Vannucchi, et al.
Leukemia & Lymphoma|January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
American Journal of Hematology|March 31, 2012
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH SymposiumOmar Abdel-Wahab, Animesh Pardanani, Olivier A Bernard, et al.
Communications Biology|May 4, 2021
Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleationMaria Feola, Andrea Zamperone, Daniel Moskop, et al.
Blood|May 6, 2006
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)Ayalew Tefferi, Giovanni Barosi, Ruben A Mesa, et al.
Nature|July 5, 2019
Somatic mutations and cell identity linked by Genotyping of TranscriptomesAnna S Nam, Kyu-Tae Kim, Ronan Chaligne, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
Pageof 21